BeiGene is developing a pipeline of oral small molecules and monoclonal antibodies to fight cancer. Get up to date with the BeiGene solid tumor pipeline and clinical trials.

BeiGene is developing a pipeline of oral small molecules and monoclonal antibodies to fight cancer. Get up to date with the BeiGene hematology pipeline and clinical trials.

Poster presented at ASH 2022 describing the results of comprehensive biomarker analyses performed in patients with B-cell malignancies, particularly diffuse large B-cell lymphoma (DLBCL), to examine biomarkers associated with response or resistance to dual BTK and PD-1 inhibition.